Developing a comprehensive response for treatment of children under 6 years of age with schistosomiasis: research and development of a pediatric formulation of praziquantel

Product development programs for neglected tropical diseases: A crucial role for expert meetings

(2017) Leonie Hussaarts et al.   PLoS Neglected Tropical Diseases

Changing Policy and Practice in the Control of Pediatric Schistosomiasis

(2015) F. Mutapi   PEDIATRICS

The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer)

(2014) P. Olliaro et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Human schistosomiasis

(2014) Daniel G Colley et al.   LANCET

Mass drug administration with praziquantel reduces the prevalence of Schistosoma mansoni and improves liver morbidity in untreated preschool children

(2014) Charles R. Cleland et al.   TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE

Schistosomiasis in African infants and preschool children: let them now be treated!

(2013) J. Russell Stothard et al.   TRENDS IN PARASITOLOGY

Practical dosing of praziquantel for schistosomiasis in preschool-aged children

(2013) Piero L. Olliaro et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Schistosomiasis in infants and pre-school-aged children in sub-Saharan Africa: implication for control

(2012) UWEM F. EKPO et al.   PARASITOLOGY

Efficacy and Safety of Praziquantel in Preschool-Aged Children in an Area Co-Endemic for Schistosoma mansoni and S. haematobium

(2012) Jean T. Coulibaly et al.   PLoS Neglected Tropical Diseases

Closing the praziquantel treatment gap: new steps in epidemiological monitoring and control of schistosomiasis in African infants and preschool-aged children

(2011) J. RUSSELL STOTHARD et al.   PARASITOLOGY

Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso

(2008) Seydou Toure   BULLETIN OF THE WORLD HEALTH ORGANIZATION